The Board
The Catalysis Foundation for Health is guided by highly accomplished individuals who serve as advisors to the Foundation on scientific, technical, business and policy matters. In addition, the Board works with the Catalysis leadership team to engage global health experts and navigate the formation and operation of public-private partnerships created to help Catalysis achieve its Mission.
Nancy A. Aossey, MBA, President and CEO, International Medical Corps
Paul R. Billings, MD, Ph.D., Director and CSO, Genomic Medicine Institute, El Camino Hospital
Julie L. Gerberding, MD, MPH, President, Merck Vaccines; Former Director, US Centers for Disease Control and Prevention
David M. Kelso, Ph.D., Director, Northwestern University Center for Innovation in Global Healthcare Technologies
John W. Peabody, MD, Ph.D., Deputy Director, Institute of Global Health, University of California, San Francisco
David H. Persing, MD, Ph.D., Executive Vice-President, Chief Medical and Technology Officer, Cepheid
Louis J. Riceberg, Ph.D., Founder and Principal, BioBridge Strategies
Richard M. Thayer, MBA, CEO, Catalysis Foundation for Health
Mickey S. Urdea, Ph.D., Chairman and CEO, Tethys Bioscience